83 Biggest Movers From Yesterday
Today, 5:55 AM
Gainers
Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.
20 Stocks Moving in Wednesday’s Pre-Market Session
Today, 5:55 AM
Gainers
Decisionpoint Systems, Inc. (NASDAQ: DPSI) rose 47.2% to $7.02 in pre-market trading after jumping around 19% on Tuesday. DecisionPoint Systems recently reported first-quarter FY22 revenue growth of 22.7% year-on-year to $19.7 million.
110 Biggest Movers From Friday
Today, 5:55 AM
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
56 Stocks Moving In Friday’s Mid-Day Session
Today, 5:55 AM
Gainers
Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
CTI BioPharma Q4 EPS $(0.38) Down From $(0.20) YoY
Today, 5:55 AM
CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.38) per share. This is a 90 percent decrease over losses of $(0.20) per share from the same period last year.
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Today, 5:55 AM
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.
63 Biggest Movers From Yesterday
Today, 5:55 AM
Gainers
Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20.20 on Thursday after jumping around 35% on Wednesday.
JMP Securities Maintains Market Outperform on CTI BioPharma, Raises Price Target to $5
Today, 5:55 AM
JMP Securities analyst Reni Benjamin maintains CTI BioPharma (NASDAQ:CTIC) with a Market Outperform and raises the price target from $4 to $5.